Hikma looking to bolster presence in Africa

(Reuters) – Jordan’s Hikma Pharmaceuticals Plc said it is looking to expand in Africa over the next two to three years, through building its own plant or by making an acquisition of up to $300 million. The company, which makes and sells branded and generic drugs, said it would be a natural progression to ramp up its presence in the African continent, given that it derives more than half its revenue from the Middle East and North Africa (MENA) region. …